Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 237-239 , October 2006

An audit of the use and complications of glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention against national UK standards

Received 20 May 2006 ,Revised 18 July 2006 ,Accepted 18 July 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1553-8389(06)00186-2

doi: 10.1016/j.carrev.2006.07.005

Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 237-239 , October 2006

Article Tools

* Image Usage & Resolution